Vegashares Trillions ETF TRIL
Set alert
As of Oct 30, 10:00 AM ET
- YTD
- -6.35%
- 1 year
- -6.35%
- Open
- 23.52
- Prev close
- 24.33
- Mkt cap
- 1.01M
- Vol
- 8
- Avg vol
- 780
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 23.52
- High
- 23.52
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2021
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 23.41
Discussion (29)
Sign in to join the discussion
Yeah, so shorts and spammers seem to be running free and loose here today...
3000 shares is not executive dumping. Sometimes people take a little profit along the way - especially when they have more options...
I’ve sold many times more than that and still have a giant pile of shares (0.37 avg...love this stock!)
$TRIL will this stock move up soon or should I keep my phone upside down?
What’s the source of the Merck rumor?
It’s interesting that out of all the combo therapy studies announced, they are continuing with one mono therapy study (primary t-cell lymphoma) because “there are no good agents available” to treat in combo...
Not just bullish as an investor - this is an exciting time to watch cancer therapies evolve!
Predictions:
April 28 - 622 data readout, multiple combo therapy stage 3 trials announced.
Price goes to 20-50$ a share.
May 1 - buyout offer.
May 2 - I pay off my mortgage.
PT for conference:
I think announcement of 622 results alone is going to be a major catalyst, but it was surmised/intimated that combo studies would be announced/discussed that day - expanded solid tumor application, etc. I believe that solidly puts tril at the stage where 47inc was when they took off.
As such, I’m very bullish that this carries us up to 20-40$ range, which will be a buyout zone.
Looks like a masacre.
Add more on $12.18. I believe science data :)
$HKIB CL
Now turning positive, yes baby thats the way I like it.